SCHEMBL25818597

SCHEMBL25818597

OBOc1ccc2ccc3ccccc3c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
HSD17B10 Q99714 3/20 0.50
HIF1A Q16665 1/20 0.50
CYP1B1 Q16678 1/20 0.50
CYP2A6 P11509 2/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HPRT1 P00492 3/20 0.43
HPGD P15428 2/20 0.41
MAPT P10636 2/20 0.41
CASP3 P42574 1/20 0.40
GFER P55789 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
CYP1A2 P05177 3/20 0.39
PTPN22 Q9Y2R2 1/20 0.36
PAX8 Q06710 1/20 0.36
TRPM4 Q8TD43 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17752309 0.91 ALDH1A1 (0.48) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
SCHEMBL25818647 0.89 HPRT1 (0.50) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
SCHEMBL10251809 0.84 ALDH1A1 (0.40) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
SCHEMBL3437809 0.84 CYP1A2 (0.52) ALDH1A1HSD17B10CYP2A6TDP1MAPT
SCHEMBL25608351 0.82 CYP1A2 (0.41) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
SCHEMBL25899334 0.82 CYP1A2 (0.45) ALDH1A1HSD17B10HIF1ACYP2A6TDP1
SCHEMBL19395165 0.82 ALDH1A1 (0.33) ALDH1A1HSD17B10HPRT1HPGDMAPT
SCHEMBL16543076 0.81 ABCG2 (0.41) ALDH1A1HSD17B10TSHRTDP1HPGD
SCHEMBL10251735 0.80 CYP11B1 (0.41) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
SCHEMBL10251715 0.80 ALDH1A1 (0.42) ALDH1A1HSD17B10HIF1ATSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 ALDH1A1 1010/4885HSD17B10 3433/4885HIF1A 3881/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 ALDH1A1 1010/4885HSD17B10 3433/4885HIF1A 3881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.